Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:direct factors Xa inhibitor drug pathway
go back to main search page
Accession:PW:0002596 term browser browse the term
Definition:The pharmacokinetics and pharmacodynamics pathway of drugs that reduce or prevent the formation of blood clots by directly inhibiting activated factor X (Xa). Factor X is a serine protease and essential component of coagulation cascade. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.


show annotations for term's descendants       view all columns           Sort by:
 

Term paths to the root
Path 1
Term Annotations click to browse term
  pathway 6016
    drug pathway 393
      blood and blood forming organs drug pathway 56
        antithrombotic drug pathway 56
          anticoagulant drug pathway 21
            direct factors Xa inhibitor drug pathway 0
              apixaban drug pathway + 0
              edoxaban drug pathway + 0
              rivaroxaban drug pathway + 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.